He died in the early hours of today due to complications from Covid-19, according to family sources.
The spokesman for the Yoruba socio-cultural organisation, Afenifere, Yinka Odumakin, is dead.
He died in the early hours of today due to complications from Covid-19, according to family sources.
Details of his death are still sketchy.
“I just spoke with Dr. Joe, his wife. She’s in a panic mode. She said a part of her is gone. Odumakin had been in the ICU of LASUTH for the past one week after being transffered from IDH Yaba,” a source said.
Odumakin was a human rights activist who played a vital role in the National Democratic Coalition (NADECO) that fought General Sani Abacha’s regime after the annulment of the June 12, 1993 election.
He was the Apex Yoruba group’s spokesman for over two decades, coordinating the publicity and public relations activities of the group.
He was also one of the Southern and Middle Belt Leaders’ Forum (SMBLF) spokespersons, the body representing ethnic nationalities in the South-West, South-South, South-East and the Middle Belt.
Odumakin, married to another activist, Dr. Joe Odumakin, has been one of the strongest critics of the present government using the platform of the Afenifere.
He has consistently taken on the Muhammadu Buhari-led Federal Government over alleged impartiality and favouritism in appointment into various offices.
His voice was also very loud in condemning the activities of killer herders in the Yorubaland.
He recently warned the Federal Government against arresting Sunday Igboho, who recently issued a quit notice to the Fulani herders in Ibarapa Oyo State and subsequently ejected the Sarkin Fulani in Igangan.
Chevron Nigeria Limited has said it will slash its workforce by 25 per cent as it is reviewing its manpower requirements in the light of the changing business environment.
CNL disclosed this on Friday in a statement entitled ‘Chevron Nigeria Limited reviews workforce in accordance with business exigencies’.
The oil major said it would continue to evaluate opportunities to improve capital efficiency and reduce operating costs.
CNL’s General Manager Policy, Government and Public Affairs, Esimaje Brikinn, said, “The aim is to have a business that is competitive and have an appropriately sized organisation with improved processes.
“This will increase efficiency and effectiveness, retain value, reduce cost, and generate more revenue for the Federal Government of Nigeria.”
According to him, the new organisational structures will, unfortunately, require approximately 25 per cent reduction in the work force across the various levels of the organisation.
“It is important to note that all our employees will retain their employment until the reorganisation process is completed,” Brikinn said.
He said there were no plans to migrate Nigerian jobs outside the country.
He said, “We have prospects for our company in Nigeria; however, we must make the necessary adjustments in light of the prevailing business climate; and we need everyone’s support to get through these tough times stronger, more efficient and more profitable, in order to sustain the business.
“We are actively engaging our workforce to ensure they understand why this is being done. We will continue to consistently engage all relevant stakeholders, including the leadership of the employee unions as we continue this process of business optimisation.” (Punch)
WASHINGTON – President Donald Trump arrived at the hospital Friday after he and first lady Melania Trump tested positive for COVID-19, raising fresh questions about the president’s health.
Trump, 74, went to Walter Reed National Military Medical Center in Bethesda, Maryland, in what aides said was a precautionary move. Officials said they expected him to be there for a few days.
Trump boarded Marine One, the presidential helicopter, en route to Walter Reed, which is about 9 miles away from the White House. Wearing a mask, he gave reporters the thumbs up as he walked across the lawn but did not stop to take questions.
Before his departure, Trump deassured the public that he and the first lady were doing well in the hours since they tested positive.
” I’m going to Walter Reed Hospital, I think I’m doing very well, but we’re going to make sure that things work out. the first lady is doing very well. So thank you very much. I appreciate it. I will never forget it. Thank you.
White House press secretary Kayleigh McEnany said the president “remains in good spirits, has mild symptoms, and has been working throughout the day.”
Get the Coronavirus Watch newsletter in your inbox. Stay safe and informed with updates on the spread of the coronavirus
“Out of an abundance of caution, and at the recommendation of his physician and medical experts, the President will be working from the presidential offices at Walter Reed for the next few days. President Trump appreciates the outpouring of support for both he and the First Lady,” she added.
The president’s diagnosis, which he tweeted just before 1 a.m. on Friday, sent shockwaves through Washington and across the country, causing markets to plummet just weeks before the presidential election.
The president received a single 8 gram dose of Regeneron’s polyclonal antibody cocktail as a precautionary measure, according to a memo from White House physician Dr. Sean Conley. The antibody cocktail is being studied in four late-stage clinical trials and its safety and efficacy have not been fully evaluated by any regulatory authority, the company said on its page.
The president also has been taking zinc, vitamin D, famotidine, melatonin and a daily aspirin, Conley said.
“As of this afternoon, the President remains fatigued but in good spirits,” Conley said, according to the memo.
Conley said the first lady was experiencing only a “mild cough and headache.” He added that other members of the president’s family are well and tested negative for COVID-19.
Trump has not posted to his Twitter account since announcing his diagnosis, an uncharacteristic move for a president who frequently tweets and retweets throughout the day.
“We’re having to hold him back a little here because he is hard at work,” White House Press Secretary Kayleigh McEnany told Fox News on Friday afternoon.
When asked whether Trump would address the nation about his health in the coming days, McEnany said: “It’s safe to say that you’ll be seeing and hearing from the president as he moves forward with his working schedule.”
Counselor to the President Hope Hicks walks from Marine One to accompany President Donald Trump aboard Air Force One as he departs Sept. 30, 2020, at Andrews Air Force Base, Md. Counselor to the President Hope Hicks walks from Marine One to accompany President Donald Trump aboard Air Force One as he departs Sept. 30, 2020, … Show more
Trump revealed his test results after one of his closest advisers, Hope Hicks, who joined the president on a series of recent trips, had been infected. Hicks began feeling symptoms on a return flight from the president’s rally in Minnesota on Wednesday and was isolated from other passengers on the plane.
White House officials knew Hicks tested positive before Trump traveled to his golf resort in Bedminster, N.J., to attend a fundraiser Thursday, Meadows confirmed.
“I can tell you in terms of Hope Hicks, we discovered that right as Marine One was taking off yesterday,” Meadows said.
He added that some people who had been traveling and in close contact with Hicks were removed from the flight, raising questions about why the president proceeded with the fundraiser, which saw him come in contact with dozens of supporters.
Vice President Mike Pence and second lady Karen Pence both tested negative. Former Vice President Joe Biden and his wife Jill Biden announced they also tested negative after coming into contact with the president at Tuesday’s first presidential debate in Cleveland, Ohio.
Officials said presidents have a suite of offices at Walter Reed, and doctors recommended that Trump use it as a precaution in light of his positive COVID test.
Aides insisted the president is fine, walking around and talking, and that this is a precautionary move.
If the president should need a procedure and becomes incapacitated, he will temporarily cede authority to Pence.
Section 3 of the 25th Amendment to the Constitution, which lays out succession should the president become incapacitated, has only been invoked three times since it was adopted in 1967.
Former President Ronald Reagan invoked it when he had surgery to remove a cancerous polyp in his large intestine in 1985 and George W. Bush twice used it when he underwent routine colonoscopies.
At 74, the president is five times more likely to be hospitalized and 90 times more likely to die of COVID-19 than someone between the ages of 18 and 29, according to the CDC.
Voters react to Trump virus test results Residents and visitors in the nation’s capital reacted to the stunning news Friday that President Donald Trump and first lady Melania Trump have both tested positive to the coronavirus. (Oct. 2) AP
Belgium has added several new areas in the European Union, including Copenhagen, Lisbon and Geneva, to its list of red zones for travellers from Friday, according to the latest updates of the Ministry of Foreign Affairs.
This means that Belgium will require travellers returning from these zones to be tested and quarantined from Friday 25 September at 4:00 PM. Up this week, Belgium also banned all non-essential travel to red-zone destinations, but from now on, travel will only be “strongly discouraged.”
Both Malta and Luxembourg will become red zones from Friday, as will the Copenhagen region in Denmark, the Lisbon metropolitan area and central region in Portugal, and the Geneva canton in Switzerland.
The Dutch province of Utrecht, and the Austrian states of Tyrol and Vorarlberg will also turn red.
For the Czech Republic, the Northwest, Central Moravia and Moravia-Silesia regions will be coloured red, and for Hungary, the Western Transdanubia, Southern Great Plain regions will too.
In France, the regions of Ariège, Calvados, Doubs, Eure, Eure-et-Loir, Haute-Loire, Landes, Loire-Atlantique, Lot-et-Garonne, Marne, Saône-et-Loire, Somme and Tarn will turn red as well.
For the United Kingdom, West Central Scotland will now also be considered a red area.
Belarusian President Aleksandr Lukashenko said last month via Belarusian Telegraph Agency, BelTA., that World Bank and IMF offered him a bribe of $940 million USD in the form of “Covid Relief Aid.” In exchange for $940 million USD, the World Bank and IMF demanded that the President of Belarus:
• imposed “extreme lockdown on his people” • force them to wear face masks • impose very strict curfews • impose a police state • crash the economy
Belarus President Aleksandr Lukashenko REFUSED the offer and stated that he could not accept such an offer and would put his people above the needs of the IMF and World Bank. This is NOT a conspiracy. You may research this yourself. He actually said this!
Now IMF and World Bank are bailing out failing airlines with billions of dollars, and in exchange, they are FORCING airline CEOs to implement VERY STRICT POLICIES such as FORCED face masks covers on EVERYONE, including SMALL CHILDREN, whose health will suffer as a result of these policies.
And if it is true for Belarus, then it is true for the rest of the world! The IMF and World Bank want to crash every major economy with the intent of buying over every nation’s infrastructure at cents on the dollar!
REPLY: Interesting claims. They certainly cannot afford countries to buck the trend if they are behind this Great Reset. The IMF and World Bank are definitely involved with Bill Gates. I do not think they are trying to buy companies for pennies on the dollar. They are trying to wipe out companies that are not GREEN!
Philippe Douste-Blazy, MD, is a cardiologist and former French Health Minister who served as Under-Secretary General of the United Nations. He was a candidate in 2017 for Director of the World Health Organization.
In a videotaped interview on May 24, 2020, Dr. Douste-Blazy provided insight into how a series of negative hydroxychloroquine studies got published in prestigious medical journals.
He revealed that at a recent Chatham House top secret, closed door meeting attended by experts only, the editors of both The Lancet and the New England Journal of Medicine expressed their exasperation, citing the pressures put on them by pharmaceutical companies.
He states that each of the editors used the word “criminal” to describe the erosion of science.
He quotes Dr. Richard Horton who bemoaned the current state of science:
“If this continues, we are not going to be able to publish any more clinical research data because pharmaceutical companies are so financially powerful; they are able to pressure us to accept papers that are apparently methodologically perfect, but their conclusion is what pharmaceutical companies want.”
Dr. Douste-Blazy supports the combination treatment –hydroxychloroquine (HCQ) and azithromycin (AZ) for Covid-19 recommended by Dr. Didier Raoult. In April, 2020
Dr. Douste-Blazy started a petition that has been signed by almost 500,000 French doctors and citizens urging French government officials to permit physicians to prescribe hydroxychloroquine to treat coronavirus patients early, before they require intensive care.
The issue has become highly politicized; the left-leaning politicians and public health officials are adamantly against the use of HCQ, whereas those leaning toward the right politically are for the right of doctors to prescribe the drug as they see fit.
The journal SCIENCE described the response to French President Emmanuel Macron trip to Marseille to meet Dr. Raoult who prescribes the combination drug regimen and he has documented their effectiveness.
However, public health officials, academic physicians and the media – all of who are financially indebted to pharmaceutical companies and their high profit marketing objectives – vehemently oppose the use of HCQ, and use every opportunity to disparage the drug by derisively referring to President Trump as its booster.
The Lancet Published a Fraudulent Study: Editor Calls it “Department of Error” by Vera Sharav Alliance for Human Research Protection
On May 22, 2020, The Lancet published “Hydroxychloroquine or Chloroquine With or Without A Macrolide For Treatment of COVID-19: a Multinational Registry Analysis”. It was described as an observational study purportedly involving more than 96,000 hospitalized Covid-19 patients in 671 hospitals across six continents. What was not disclosed is the fact that the two lead co-authors have significant, relevant financial conflicts of interest that just may have biased the reported findings.
Dr. Sapan Desai
Mandeep Mehra, MD
The database belongs to Surgisphere Corporation whose founder and CEO, is Dr. Sapan Desai, who is a lead co-author of the study. Dr. Desai has refused to disclose the data – for independent confirmatory review. In fact, he refuses to identify the participating hospitals, or even the countries. Dr. Mandeep Mehra, the lead co-author is a director at Brigham & Women’s Hospital, which is credited with funding the study. Dr. Mehra and The Lancet failed to disclose that Brigham Hospital has a partnership with Gilead and is currently conducting TWO trials testing Remdesivir, the prime competitor of hydroxychloroquine for the treatment of COVID-19, the focus of the study.
The Lancet report claimed that COVID-19 “patients treated with hydroxychloroquine (with or without a macrolide) were at increased risk of de-novo ventricular arrhythmia and ‘a greater hazard for in-hospital death.’” Such an alarming finding from an inaccessible dataset should have raised concerns for the editor of the Lancet, about the integrity of the study and the accuracy of the claimed findings. In fact, within days of the Lancet publication, concerns about that dataset were raised on social media, on PubPeer, the post-publication discussion website, and in newspapers.
Within days of publication, Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases (NIAID) declared on CNN
“The scientific data is really quite evident now about the lack of efficacy.”
A media blitz against hydroxychloroquine (HCQ) created panic: clinical trials aimed at testing hydroxychloroquine for COVID-19 were suspended by International public health institutions including the World Health Organization the UK government regulatory agency and the French government.
The chief scientist at the WHO, Soumya Swaminathan, stated that although the Lancet data weren’t from a randomized controlled trial, the data were compelling because they
“came from multiple registries and quite a large number of patients, 96,000 patients.”
Knowledgeable scientists and experienced clinicians around the world were skeptical The alarming findings and serious negative impact of the Lancet report led numerous scientists around the globe to scrutinize the report in detail. That scrutiny by legitimate, independent scientists has led to many serious questions about the integrity of the study, the authenticity of the data, and the validity of the methods the authors used.
An Open Letter posted online, is addressed to the authors of the report: Mandeep R Mehra, MD, Sapan S Desai, MD, Frank Ruschitzka, MD, Amit N Patel, MD, and to the editor, Dr. Richard Horton. The letter was signed by more than 200 prominent scientists across the world, including 17 from institutions in Africa.
The scientists question the evidence for claimed serious risks posed from the use of hydroxychloroquine in COVID-19 patients. Among the concerns raised by the scientists are the following:
A range of gross deviations from standard research and clinical practices, such as: patients were prescribed inexplicably high daily doses of hydroxychloroquine –far higher than the FDA-recommended doses. There was no ethics review. The number of patients reportedly from Australia far exceeded the number of patients in the Australian government database;. Gross misrepresentation of the numbers of deaths in Australia. “Both the number of cases and deaths [the claimed 40% deaths in Africa], and the details provide seem unlikely.” Refusal to identify the hospitals that contributed patient data. The ratios of patients who received chloroquine (49 %) to those who received hydroxychloroquine (50% ) are implausible; in Australia chloroquine is not available without special government authorization. The Guardian reported on May 28th that it could not confirm that UK’s health agencies had even provided data for the study.
On May 29th The New York Times reported that 100 scientists and clinicians raised serious questions about the validity of the The Lancet report findings. It reported that on May 29th Dr. Mehra issued the following statement:
“We leveraged the data available through Surgisphere to provide observational guidance to inform the care of hospitalized Covid-19 patients”
[Perhaps someone can translate what “leveraged the data” means ….? The Times understated the number of scientists who signed the open letter; it is closer to 220.]
Dr. James Watson
Dr. James Watson, senior scientist at the MORU-Oxford Tropical Medicine Research Unit in Thailand doubts that any research organization could have obtained such detailed massive records for so many people in Africa that quickly. Based on healthcare workers’ descriptions of medical record-keeping, at many hospitals in Africa, he indicated:
“I just find it very hard to believe.”
Dr. Watson contributed concerns regarding the African data to the Open Letter. He had to suspend a just-launched trial of HCQ to comply with UK regulators following the Lancet report.
Dr. Anthony Etyang, a consultant physician and clinical epidemiologist with the KEMRI-Wellcome Trust Research Programme in Kenya, who is also a signatory to the Open Letter, wrote to The Scientist expressing his doubts about the numbers of African patients in the Surgisphere dataset, noting that even private hospitals on the continent have poor medical records.
Rather than investigating the serious issues raised about the integrity of the report, The Lancet editor posted the authors’ claimed to “correction” of the numbers of patients in Asia and Australia on a page designated “Department of Error” – whatever that means!
The nature and number of the serious “discrepancies” that have emerged following the Lancet publication of the Surgisphere “study,” lead one to suspect out-and-out FRAUD.
Disputed Hydroxychloroquine Study Brings Scrutiny to Surgisphere, an investigative report by Catherine Offord in The SCIENTIST, May 30, 2020, looked deeper than others and uncovered background information about Dr. Desai and the changes in Surgisphere’s product line and his marketing methods. In 2008, Surgisphere was the publisher of medical textbooks that ran afoul when physicians complained about falsified rave reviews. In 2010, Surgisphere became a high impact, online medical journal, whose website boasts that it
“accrued over 50,000 subscribers spanning almost every country around the world… with almost one million page views per month.”
The Journal of Surgical Radiology had a three-year run; its last issue was published in January 2013.
The Scientist reports that Dr. Desai is named in three medical malpractice lawsuits that were filed during the second half of 2019.
Additional disturbing facts about Surgisphere have been uncovered by a team of investigative reporters — Melissa Davey, Stephanie Kirchgaessner, and Sarah Boseley – for The Guardian.
Surgisphere, the company that provided the database for studies published by two of the world’s leading medical journals – The Lancet and The New England Journal of Medicine – based on Surgisphere data. The studies were co-authored the hydroxychloroquine studies.
“Surgisphere’s employees have little or no data or scientific background. An employee listed as a science editor appears to be a science fiction author and fantasy artist. Another employee listed as a marketing executive is an adult model and events hostess… until Monday, the “get in touch” link on Surgisphere’s homepage redirected to a WordPress template for a cryptocurrency website, raising questions about how hospitals could easily contact the company to join its database.”
The fiasco of the publication of essentially fraudulent reports in the journals with the greatest impact on both clinical treatment and public health policies, reveals how thoroughly corrupted so-called peer review has become because it lacks external, independent review by scientists who have NO STAKE in the study outcome. It was only after the reports by The Scientist andThe Guardian, that the editors of The NEJM and The Lancet were compelled to issue an: “Expression of concern.” This fiasco demonstrates why intelligent people seek alternative sources for reliable information.
The website, Science Defies Politics exposes numerous scientifically invalid studies that were essentially “hit jobs” against the use of hydroxychloroquine.
WHY are very powerful corporate-government stakeholders so intent on killing a drug with a 70 year track record? Because the drug works against the pandemic; it is readily available, and costs very little. Therefore, it poses a financial threat to both pharma companies and their partners in government and academia, those who are intent on profiting from the COVID-19 pandemic.
As uncovered by Science Defies Politics: 16 of the panel members selected by NIH to formulate the official COVID-19 Treatment Guidelines – including two of the three co-chairs – were paid by Gilead. They issued guidelines that raised fear, uncertainty, and doubt about the use of HCQ combined with AZ, while raising no fear, doubt, or uncertainty about using Gilead’s unproven, unapproved, drug remdesivir; a drug that has shown mediocre performance in clinical trials. Seven of the NIH panelists failed to disclose their financial ties to Gilead. They are listed here.
The medical scientific literature is infested with financially motivated, shoddy, studies aimed at promoting products and, when a life-saving, non-patentable product, proves effective, scientists are hired to author study reports that are designed to tarnish scientists’ reputations, and to proclaim findings that refute legitimate findings. In this case, studies designed to “debunk” the effectiveness of hydroxychloroquine against COVID-19.
Examples of countries and physicians who have witnessed the effectiveness of the HCQ – Az combination as a treatment for covid-19, are viewed by corporate-government collaborating partners as posing a major threat to their marketing agendas.
For example, Senegal and India are putting their hopes in hydroxychloroquine, marketed by Sanofi, under the trade name Plaquenil. A Sanofi spokesperson stated:
“We are providing the drug to hospitals and doctors to enable them to carry out clinical trials to determine whether hydroxychloroquine is effective or not, but not to treat Covid-19.”
On May 23rd the Indian Council of Medical Research (ICMR) issued expanded revised guidelines for use of hydroxychloroquine (HCQ) for COVID-19:
“The Joint Monitoring Group and the NTF have recommended prophylactic use of HCQ in asymptomatic frontline workers, such as surveillance workers deployed in containment zones and paramilitary/police personnel involved in Covid-19 related activities, asymptomatic household contacts of laboratory confirmed cases and all asymptomatic healthcare workers involved in containment and treatment of Covid-19 and working in non-Covid hospitals/non-Covid areas of Covid hospitals/blocks.”
Didier Raoult, MD, PhD — “a Science Star” — as the NYT described him in a recent profile, who has identified 500 novel species of human-borne bacteria; a scientist known all over the world as the discoverer of the first giant virus, a discovery that earned him the Grand Prix, one of France’s most prestigious awards.
Didier Raoult, MD, PhD
Dr. Raoult is the founder and director of the research hospital, the Institut Hospitalo-Universitaire Méditerranée Infection (IHU). He is a professor on the faculty of Medicine of Ais-Marseille University, and since 2008, he has been the director of the Infectious and Tropical Emergent Diseases Research Unit), which employs more than 200 people and runs a hospital with 3,700 patients. He has more than 2,300 indexed publications and was classified among the ten leading French researchers by the journal Nature. Dr. Raoult has a reputation for bluster but also for creativity that others lack. As the Times noted, “He looks where no one else cares to, with methods no one else is using, and [he] finds things.”
Since publishing favorable reports about a treatment combination of two cheap, widely prescribed medicines: hydroxychloroquine and the antibiotic azithromycin, as a treatment of choice against Covid-19, Dr. Raoult has become the subject of intense demonization by the corporate-influenced medical establishment, the media, and the who resort to this tactic whenever they lack evidence or legitimate grounds to support public health policies that cause people harm. Their fallback tactic is to demonize every doctor who challenges them and refuses to adhere to their financially – driven prescribing decrees.
Dr. Raoult’s latest scientific report about HCQ, Early Diagnosis and Management of COVID-19 Patients: A Real-Life Cohort study of 3,737 Patients, Marseille, France was posted on May 27, 2020,
It is a retrospective study report of the clinical management of 3,737 patients, including 3,054 (81.7%) treated with hydroxychloroquine and azithromycin (HCQ-AZ) for at least three days and 683 (18.3%) patients treated with other methods. Outcomes were death, transfer to the intensive care unit (ICU), ≥ 10 days of hospitalization and viral shedding.
“Treatment with HCQ-AZ was associated with a decreased risk of transfer to the ICU or death (HR 0.19 0.12-0.29), decreased risk of hospitalization ≥10 days (odds ratios 95% CI 0.37 0.26-0.51) and shorter duration of viral shedding (time to negative PCR: HR 1.27 1.16-1.39). QTc prolongation (>60 ms) was observed in 25 patients (0.67%) leading to the cessation of treatment in 3 cases. No cases of torsade de pointe or sudden death were observed.
Conclusion Early diagnosis, early isolation and early treatment with at least 3 days of HCQ-AZ result in a significantly better clinical outcome and contagiosity in patients with COVID-19 than other treatments.”
In France, doctors who have followed the research of Dr. Raoult, and have themselves witnessed the effectiveness of the HCQ-AZ combination, are suing the government. They demand the right to treat their patients with these drugs before easing of the lockdown. They seek to prevent complications and deaths from a second wave of Covid-19.
Violaine Guerin, MD
Dr. Violaine Guérin, an endocrinologist who conducted a trial on 100 doctors infected with COVID-19, and their families, reported her study findings that demonstrated the effectiveness of prescribing HCQ combined with azithromycin at the first sign of symptoms. The drugs substantially reduced the viral load of Covid-19:
“Taking hydroxychloroquine and azithromycin on the outset of flu symptoms can prevent Covid-19 from getting worse. We can treat people now before they end up on a ventilator.”
Her findings replicated those Dr. Didier Raoult.
Dr. Guérin recommends prescribing hydroxychloroquine for health workers infected by the coronavirus, which is outside of its approved uses. Health unions in France warned that almost 12,000 health care professionals out of 550,000 – roughly a quarter of the country’s health force – were sick with Covid-19. Dr. Guérin recommends its use on compassionate grounds, stating:
“From the very beginning, doctors have been calling for the right to self-prescribe because they are the ones on the frontline of the coronavirus battle. We cannot waste time when we can treat Covid-19 now, as long as this is done in the early stages of the virus and patients are screened for pre-existing medical conditions.”
Soon after this favorable study was published, the Minister of Health Olivier Veran in bald political arm twisting fashion, asked the highest health authority to review its authorization for the use of HCQ to treat Covid, suggesting further restriction.
From 8 June, there will be new rules in place for entering the UK because of coronavirus (COVID-19). The rules are for residents and visitors.
These rules are detailed out in the website for visitors and residents alike to acquaint themselves with the rules, how to handle them and possible fines when they are not properly followed.
The Republican News brought the entire information for the benefits of our readers and they could visit the site and have detailed information.
The coronavirus pandemic has changed how we travel, at least for a foreseeable future until sometimes else is done to change it. Every could remember how the underwear bomber helped to transform forever how travelers are screened in the airports across the entire globe.
Coronavirus (COVID-19) and entering or returning to the UK
Once the rules come into place you may be fined £100 if you refuse to provide your contact details, £1,000 if you refuse to self-isolate in England and Wales, or you could face further action. You’ll be able to find more information on enforcement measures in Scotland and Northern Ireland on this page soon.
You should also download the NHS contact tracing app. You’ll be able to find the app on this page when it’s available.
Provide your journey and contact details when you travel to the UK
From 8 June, if you’re travelling to the UK you’ll need to fill in an online form to provide your journey and contact details before you travel.
You’ll be able to find the form on this page when it’s available – check again before you travel.
You might need to show that you’ve completed the form when you arrive at the UK border.
If you refuse to fill in the form, you may be fined. You also may not be allowed to enter the UK (unless you’re either British or a UK resident).
The government will use this information to contact you if you or someone you’ve travelled with develops coronavirus symptoms, and to check that you’re self-isolating for the first 14 days after you arrive in the UK.
If you develop coronavirus symptoms when you’re travelling to the UK, tell the crew or driver on your plane, ferry, train or bus. They’ll let staff in the airport, port or station know, so they can tell you what you should do next when you arrive.
Self-isolate for your first 14 days in the UK
When you arrive in the UK, go straight to the place where you will self-isolate. Your friends or family can collect you from the airport, port or station. Only use public transport if you have no other option. If you do use public transport, wear something that covers your nose and mouth and stay 2 metres apart from other people.
You must not leave the place you’re staying for 14 days.
You can only leave if:
you need urgent medical treatment
you need support from social services
you need food and medicine and cannot get them delivered or get a friend or family member to bring them
you’re going to the funeral of a close relative, or for other compassionate reasons
there’s an emergency, for example there’s a fire at the place you’re staying
You cannot have visitors, including friends and family, unless they are providing essential care.
If you’re at home or staying with friends or family, avoid contact with the people you’re staying with and minimise the time you spend in shared areas.
If you’re staying in a hotel or guest house, you cannot use shared areas such as bars, restaurants, health clubs and sports facilities. Stay 2 metres away from all other guests and staff.
If you will not be able to safely self-isolate at the place you’re planning to stay, tell Border Force officers when you arrive in the UK. They’ll give you a choice of accommodation to stay at.
After 14 days
If you do not have any coronavirus symptoms after 14 days, you can stop self-isolating. You will then need to follow the same rules as people who live in the UK. Check the rules for the nation you’re staying in:
Some Western diplomats on Friday warned that with the current and abysmal way the Nigerian Government was handling the Coronavirus outbreak, the number of infections could witness a significant rise in the coming weeks.
Already, Nigeria has 81 confirmed cases and one recorded death of the pandemic.
According to the diplomatic community, infections could rise to more than 10,000 in the coming weeks as there are at least 5,000 persons, who had come in contact with infected persons in Nigeria already.
This category of persons, it was gathered, had gone ahead to mingle with thousands of others in the society without realising that they had the virus.
“This is the real danger. A lot of people who have had contacts with original carriers of the virus don’t even know they have the ailment and have in fact gone ahead to mingle with hundreds and thousands of others in the society, spreading the virus further.
“From information we have in the diplomatic community, there could be an explosion of confirmed infections in the coming weeks. It is going to disrupt a lot of things,” a senior diplomat attached to one European high commission in Nigeria told SaharaReporters on Friday.
Echoing the same sentiment, another diplomat, whose country has provided technical support to African nations battling the spread of the virus, said the situation in Nigeria was dire because the number of untested infections far outweighed those examined by government agencies.
So far, only around 200 persons have been tested for Coronavirus in Nigeria due to the unavailability of testing kits.
Though Chinese billionaire, Jack Ma, has donated testing kits and protective items to Nigeria and other African countries to help combat the virus, hundreds of potentially infected persons are yet to be examined in Nigeria, increasing the risk of an epidemic in the West African state.
“We could be having tens of thousands of confirmed cases across Nigeria in a few days from now.
“There are thousands of people with the virus already on the loose in the country and many of this people cannot be traced. They have taken this pandemic into every nook and cranny of this country.
“I think Nigeria must act fast to avert a full-blown war,” the diplomat said on Friday, adding that Western countries will continue to provide technical support to help Africa and the rest of the world conquer the virus.
Already, there have been reported cases of people being asked to self-isolate after reporting to health agencies of having symptoms of the virus.
Without proper monitoring and stringent measures to ensure such persons do not expose others to infection in case they have the virus, thousands of individuals in this category have gone on with their daily activities and opened up the chance of an epidemic in the country.
Unwilling to take chances, some Western countries are already evacuating their citizens from Nigeria and other African countries.
For example, an Air France flight on Thursday moved 260 Europeans from Nigeria to France to prevent them from being infected with the virus.
This came after the Nigerian Government granted a one-week permission to Air France and KLM to evacuate Europeans from the country following the continued spread of the pandemic.
Also on Thursday, British High Commissioner to Nigeria, Ms. Catriona Laing CB, said the mission was exploring available options to send staff and their families back to the United Kingdom.
This was occasioned by projections by experts and top diplomats that the Coronavirus pandemic could explode in Nigeria and other African countries in the coming days.
But according to the World Health Organisation, Nigeria and other African countries battling the virus must conduct more tests to portray the true picture of things and avert a major crisis.
Lagos markets, offices, showrooms, and warehouses operating under the umbrella of Market Leaders and Traders Association of Nigeria, Lagos Chapter, will shut down, on Friday, over the raging coronavirus epidemic.
In a statement issued this morning and signed by Comrade Christopher Okpala and Comrade Okey Enwuru, president and secretary respectively, the shutdown will run from March 27 to April 4 in the entire city of Lagos.
Residents and members were asked to use the grace windows between today (Tuesday) and Thursday, to stock their homes of foodstuff in Lagos.